Globex International

Wegovy 0.25mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

Wegovy 0.25mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.

The most common side effects of Wegovy 0.25mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 0.25mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Additionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.25mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Wegovy Injection

• Management of Obesity
• Risk reduction of Heart disease

Wegovy 1mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

Wegovy 1mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.

The most common side effects of Wegovy 1mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 1mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Additionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

USES OF WEGOVY INJECTION

• Management of Obesity
• Risk reduction of Heart disease

Wegovy 0.5mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

Wegovy 0.5mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.

The most common side effects of Wegovy 0.5mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 0.5mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Additionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.5mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Wegovy Injection

• Management of Obesity
• Risk reduction of Heart disease

Wegovy 1.7mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

Wegovy 1.7mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.

The most common side effects of Wegovy 1.7mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 1.7mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Additionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1.7mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Wegovy Injection

• Management of Obesity
• Risk reduction of Heart disease

Mounjaro (tirzepatide) 5 mg per 0.5 mL injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

It is a single molecule designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.

Mounjaro represents a different class of medicines introduced for adults with type 2 diabetes. It works differently by directly activating GIP and GLP-1 pathways to help regulate blood sugar.

Mounjaro 2.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 2.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 2.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 2.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 7.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 7.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 7.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 7.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 7.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 10mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 10mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 10mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 10mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 10mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 10mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 12.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 12.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 12.5mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Mounjaro 15mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.

Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 15mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.

Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Mounjaro 15mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 15mg KwikPen.

Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.

Uses of Mounjaro Solution for Injection

• To improve glycemic control in adults with Type 2 diabetes mellitus
• Management of Obesity

Wegovy 2.4mg FlexTouch is a medicine that aids in weight loss and maintenance for overweight or obese adults. It also helps lower the risk of heart-related events like heart attacks and strokes in adults with heart disease who are obese or overweight. It works best with a low-calorie diet and exercise.

Wegovy 2.4mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the medicine, maintain a healthy diet and regular physical activity for maximum benefits.

The most common side effects of Wegovy 2.4mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage, however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 2.4mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Additionally, discuss with your doctor if you're on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 2.4mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

USES OF WEGOVY INJECTION

• Management of Obesity
• Risk reduction of Heart disease

Noveltreat 0.25 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 0.25 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 0.25 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 0.25 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 0.25 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 0.25 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 0.25 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Noveltreat Pre-filled Pen

• Management of Obesity
• Risk Reduction of Heart disease

Noveltreat 0.5 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 0.5 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 0.5 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 0.5 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 0.5 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 0.5 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 0.5 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Noveltreat Pre-filled Pen

• Management of Obesity
• Risk Reduction of Heart disease

Noveltreat 1 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 1 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 1 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 1 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 1 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 1 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 1 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Noveltreat Pre-filled Pen

• Management of Obesity
• Risk Reduction of Heart disease

Noveltreat 1.7 mg Pre-filled Pen is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.

Noveltreat 1.7 mg Pre-filled Pen is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Noveltreat 1.7 mg Pre-filled Pen is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Noveltreat 1.7 mg Pre-filled Pen is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Noveltreat 1.7 mg Pre-filled Pen include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Noveltreat 1.7 mg Pre-filled Pen, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Noveltreat 1.7 mg Pre-filled Pen with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Uses of Noveltreat Pre-filled Pen

• Management of Obesity
• Risk Reduction of Heart disease